WallStreetZenWallStreetZen

NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Reviva Pharmaceuticals Holdings earnings were -$27.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest RVPH earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$6.1M, down 5.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RVPH reported annual earnings of -$29.9M, with -23.8% growth.

RVPH earnings history

Current Revenue
$0.0
Current Earnings
-$27.1M
Current Profit Margin
0%

RVPH Return on Equity

Current Company
N/A
Current Industry
-10%
Current Market
30.7%

RVPH undefined

Current Company
-259.2%
Current Industry
-0.2%
RVPH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RVPH announces earnings.

RVPH undefined

Current Company
6,117.56%
Current Industry
6.4%
RVPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RVPH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RVPH-$27.07M-$27.11MN/A-$0.65
PPBT$3.26M$2.61MN/AN/A
KZR-$68.34M-$70.79MN/A-$9.69
CLGN-$12.54M-$13.00MN/A-$1.13
NRSN-$8.86M-$8.66MN/A-$0.36
View Top Biotech Stocks

Reviva Pharmaceuticals Holdings Earnings Reports & History FAQ

What were Reviva Pharmaceuticals Holdings's earnings last quarter?

On RVPH's earnings call on Invalid Date, Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q2 2025 earnings per share (EPS) of -$0.12, up 53.85% year over year. Total RVPH earnings for the quarter were -$6.05 million. In the same quarter last year, Reviva Pharmaceuticals Holdings's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.

Is Reviva Pharmaceuticals Holdings profitable or losing money?

As of the last Reviva Pharmaceuticals Holdings earnings report, Reviva Pharmaceuticals Holdings is currently losing money. Reviva Pharmaceuticals Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$27.11 million, a 24.68% decrease year over year.

What was RVPH's earnings growth in the past year?

As of Reviva Pharmaceuticals Holdings's earnings date in Invalid Date, Reviva Pharmaceuticals Holdings's earnings has grown year over year. RVPH earnings in the past year totalled -$27.11 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.